← brief for 2026-08-30 · People & money

Risk of Heart Failure Hospitalization Associated With Hypoxia‐Inducible Factor Prolyl Hydroxylase Inhibitors Versus Erythropoiesis‐Stimulating Agents: A Nationwide Claims‐Based Cohort Study

Paper No results yet Peer reviewed

Key takeaways

This study compared heart hospitalization rates in people taking two types of kidney-disease drugs — HIF inhibitors and older erythropoiesis-stimulating agents. It used insurance records, not a trial, so it shows only a possible link, not proof of cause or effect.

Who did this work

Yuki Kunitsu (Kyoto University Hospital) · Keiko Ikuta (Kyoto University Hospital) · Daiki Hira (Kyoto University) · Shunsaku Nakagawa (Kyoto University Hospital) · Tomohiro Terada (Kyoto University Hospital)

Source

Paper · OpenAlex, CKD works · 2026-08-29
https://doi.org/10.1002/pds.70453